Pharmaceutical Sales Certification (PSC) Exam Practice Test Bank
– Newest Complete Questions & Answers with Comprehensive
Compliance & Pharmacology Rationales – PhRMA Code, FDA
Rules, Data Deciles, and Selling Skills (Latest 2026/2027 Edition)
PDF
⚖️ Section 1: FDA Regulations, Ethical Compliance, & PhRMA Code Guidelines
1. According to the PhRMA Code on Interactions with Healthcare Professionals,
which of the following is an acceptable practice regarding the provision of meals to
physicians?
A) Treating a physician and their spouse to an upscale dinner at a local luxury restaurant to
build a commercial relationship.
B) Providing an occasional, modest meal inside a physician's office or clinic in
conjunction with an informational educational presentation.
C) Distributing restaurant gift cards worth $50 to any clinician who agrees to attend a virtual
product launch.
D) Funding a clinic’s end-of-year holiday party as an administrative goodwill gesture.
Rationale: The PhRMA Code restricts interactions between pharmaceutical
representatives and healthcare providers. It permits occasional, modest meals only if they
are directly connected to an educational presentation and occur within an office or hospital
setting. Meals cannot be provided to guests or spouses.
2. Under the Federal Anti-Kickback Statute (AKS), what constitutes a prohibited
behavior for a pharmaceutical sales representative?
A) Providing an FDA-approved product package insert detailing newly discovered drug
safety updates.
,B) Offering anything of value, such as cash, speakership fees, or lavish gifts, to a
physician to induce or reward them for prescribing a specific medication covered by
federal programs.
C) Delivering complimentary, labeled starter samples to an authorized clinic for distribution
to low-income patients.
D) Arranging an educational seminar featuring a certified third-party clinical researcher
speaking on peer-reviewed data.
Rationale: The Anti-Kickback Statute is a criminal law that prohibits giving or receiving
remuneration to induce or reward the prescription, purchase, or recommendation of any
drug covered by federal healthcare programs like Medicare or Medicaid.
3. A pharmaceutical representative is asked by a physician if a newly launched Type
2 Diabetes drug can be safely prescribed for weight loss in non-diabetic pediatric
patients. If this use is not FDA-approved, how must the representative respond?
A) Provide a detailed sales pitch highlighting the drug's efficacy in adult off-label weight loss
studies.
B) Refuse to proactively promote or recommend the drug for that specific use, as
pharmaceutical companies are legally forbidden from off-label marketing.
C) Tell the physician that they can prescribe it immediately and offer free starter samples
specifically for pediatric use.
D) Fabricate an approval confirmation to secure the account before a competitor arrives.
Rationale: Federal law prohibits pharmaceutical companies and their representatives
from marketing or promoting medications for off-label (non-FDA-approved) uses. Reps must
remain within the boundaries of the approved product label during sales interactions.
4. What must a pharmaceutical representative do if an HCP explicitly requests a peer-
reviewed journal article regarding an off-label use of an approved drug?
,A) Personally print out the article and use it as a core marketing brochure during sales calls.
B) Forward the request directly to the company's Medical Affairs or Medical
Information department for a neutral, non-promotional fulfillment.
C) Text a digital link to the article directly to the physician's personal cell phone with a
promotional comment.
D) Refuse the request completely and tell the physician that asking about off-label data is
illegal.
Rationale: Reps cannot distribute off-label data directly. When an HCP makes an
unsolicited request for off-label information, the representative must forward it to the
company’s independent Medical Affairs division to avoid violating off-label promotion laws.
5. Under the Physician Payments Sunshine Act (Open Payments), what information
must a pharmaceutical company report to the federal government regarding their
sales representatives' interactions?
A) The total number of mileage hours driven by a representative inside a sales territory.
B) All transfers of value (including meals, travel, educational materials, and speaker
fees) valued at or above the statutory minimum made to physicians and teaching
hospitals.
C) The exact names of the patients who received complimentary starter samples from a
clinic.
D) The specific sales commission structure paid to individual field agents.
Rationale: The Sunshine Act requires pharmaceutical manufacturers to report transfers
of value made to covered healthcare providers to the Centers for Medicare & Medicaid
Services (CMS) annually, promoting transparency.
, 6. Which regulatory body is responsible for monitoring and enforcing laws regarding
prescription drug advertising, labeling, and promotional accuracy in the United
States?
A) The Federal Trade Commission (FTC) exclusively
B) The FDA’s Office of Prescription Drug Promotion (OPDP)
C) The Centers for Disease Control and Prevention (CDC)
D) The Drug Enforcement Administration (DEA)
Rationale: The OPDP, a division within the FDA, directly reviews prescription drug
advertising, internet marketing, and sales materials to ensure all promotional claims are
truthful, balanced, and fully compliant with labeling regulations.
7. What is the operational definition of a "Black Box Warning" (Boxed Warning) on a
pharmaceutical product label?
A) A warning indicating that the product container must be kept inside a dark room to
prevent chemical degradation.
B) The FDA's most stringent warning, alerting healthcare providers to serious, life-
threatening, or fatal adverse risks associated with the drug.
C) An administrative note stating that the drug is currently undergoing open-market price
variations.
D) A label marking that limits the use of the drug exclusively to active-duty military
personnel.
Rationale: A Boxed Warning is the highest level of alert placed on a drug label by the
FDA. It highlights significant safety hazards, such as serious side effects or fatal drug
interactions, which reps must acknowledge during presentations.
8. A representative wants to distribute an educational anatomical model to a clinic.
According to the PhRMA Code, what requirement must this item satisfy?
– Newest Complete Questions & Answers with Comprehensive
Compliance & Pharmacology Rationales – PhRMA Code, FDA
Rules, Data Deciles, and Selling Skills (Latest 2026/2027 Edition)
⚖️ Section 1: FDA Regulations, Ethical Compliance, & PhRMA Code Guidelines
1. According to the PhRMA Code on Interactions with Healthcare Professionals,
which of the following is an acceptable practice regarding the provision of meals to
physicians?
A) Treating a physician and their spouse to an upscale dinner at a local luxury restaurant to
build a commercial relationship.
B) Providing an occasional, modest meal inside a physician's office or clinic in
conjunction with an informational educational presentation.
C) Distributing restaurant gift cards worth $50 to any clinician who agrees to attend a virtual
product launch.
D) Funding a clinic’s end-of-year holiday party as an administrative goodwill gesture.
Rationale: The PhRMA Code restricts interactions between pharmaceutical
representatives and healthcare providers. It permits occasional, modest meals only if they
are directly connected to an educational presentation and occur within an office or hospital
setting. Meals cannot be provided to guests or spouses.
2. Under the Federal Anti-Kickback Statute (AKS), what constitutes a prohibited
behavior for a pharmaceutical sales representative?
A) Providing an FDA-approved product package insert detailing newly discovered drug
safety updates.
,B) Offering anything of value, such as cash, speakership fees, or lavish gifts, to a
physician to induce or reward them for prescribing a specific medication covered by
federal programs.
C) Delivering complimentary, labeled starter samples to an authorized clinic for distribution
to low-income patients.
D) Arranging an educational seminar featuring a certified third-party clinical researcher
speaking on peer-reviewed data.
Rationale: The Anti-Kickback Statute is a criminal law that prohibits giving or receiving
remuneration to induce or reward the prescription, purchase, or recommendation of any
drug covered by federal healthcare programs like Medicare or Medicaid.
3. A pharmaceutical representative is asked by a physician if a newly launched Type
2 Diabetes drug can be safely prescribed for weight loss in non-diabetic pediatric
patients. If this use is not FDA-approved, how must the representative respond?
A) Provide a detailed sales pitch highlighting the drug's efficacy in adult off-label weight loss
studies.
B) Refuse to proactively promote or recommend the drug for that specific use, as
pharmaceutical companies are legally forbidden from off-label marketing.
C) Tell the physician that they can prescribe it immediately and offer free starter samples
specifically for pediatric use.
D) Fabricate an approval confirmation to secure the account before a competitor arrives.
Rationale: Federal law prohibits pharmaceutical companies and their representatives
from marketing or promoting medications for off-label (non-FDA-approved) uses. Reps must
remain within the boundaries of the approved product label during sales interactions.
4. What must a pharmaceutical representative do if an HCP explicitly requests a peer-
reviewed journal article regarding an off-label use of an approved drug?
,A) Personally print out the article and use it as a core marketing brochure during sales calls.
B) Forward the request directly to the company's Medical Affairs or Medical
Information department for a neutral, non-promotional fulfillment.
C) Text a digital link to the article directly to the physician's personal cell phone with a
promotional comment.
D) Refuse the request completely and tell the physician that asking about off-label data is
illegal.
Rationale: Reps cannot distribute off-label data directly. When an HCP makes an
unsolicited request for off-label information, the representative must forward it to the
company’s independent Medical Affairs division to avoid violating off-label promotion laws.
5. Under the Physician Payments Sunshine Act (Open Payments), what information
must a pharmaceutical company report to the federal government regarding their
sales representatives' interactions?
A) The total number of mileage hours driven by a representative inside a sales territory.
B) All transfers of value (including meals, travel, educational materials, and speaker
fees) valued at or above the statutory minimum made to physicians and teaching
hospitals.
C) The exact names of the patients who received complimentary starter samples from a
clinic.
D) The specific sales commission structure paid to individual field agents.
Rationale: The Sunshine Act requires pharmaceutical manufacturers to report transfers
of value made to covered healthcare providers to the Centers for Medicare & Medicaid
Services (CMS) annually, promoting transparency.
, 6. Which regulatory body is responsible for monitoring and enforcing laws regarding
prescription drug advertising, labeling, and promotional accuracy in the United
States?
A) The Federal Trade Commission (FTC) exclusively
B) The FDA’s Office of Prescription Drug Promotion (OPDP)
C) The Centers for Disease Control and Prevention (CDC)
D) The Drug Enforcement Administration (DEA)
Rationale: The OPDP, a division within the FDA, directly reviews prescription drug
advertising, internet marketing, and sales materials to ensure all promotional claims are
truthful, balanced, and fully compliant with labeling regulations.
7. What is the operational definition of a "Black Box Warning" (Boxed Warning) on a
pharmaceutical product label?
A) A warning indicating that the product container must be kept inside a dark room to
prevent chemical degradation.
B) The FDA's most stringent warning, alerting healthcare providers to serious, life-
threatening, or fatal adverse risks associated with the drug.
C) An administrative note stating that the drug is currently undergoing open-market price
variations.
D) A label marking that limits the use of the drug exclusively to active-duty military
personnel.
Rationale: A Boxed Warning is the highest level of alert placed on a drug label by the
FDA. It highlights significant safety hazards, such as serious side effects or fatal drug
interactions, which reps must acknowledge during presentations.
8. A representative wants to distribute an educational anatomical model to a clinic.
According to the PhRMA Code, what requirement must this item satisfy?
